We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+17.66%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$139M
AUM Growth
-$36.7M
Cap. Flow
-$54M
Cap. Flow %
-38.93%
Top 10 Hldgs %
19.06%
Holding
117
New
26
Increased
16
Reduced
43
Closed
32

Top Buys

Rank Stock Value
1
LAD icon
Lithia Motors
LAD
+$2.3M
2
RGEN icon
Repligen
RGEN
+$1.87M
3
GIMO
Gigamon Inc.
GIMO
+$1.82M
4
ATRC icon
AtriCure
ATRC
+$1.75M
5
AMN icon
AMN Healthcare
AMN
+$1.73M

Sector Composition

Rank Sector Weight
1 Technology 26.37%
2 Healthcare 24.99%
3 Consumer Discretionary 16.14%
4 Financials 9.24%
5 Industrials 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTSH
51
DELISTED
Tile Shop Holdings
TTSH
$1.39M 1%
+97,995
New +$1.32M
FANG icon
52
Diamondback Energy
FANG
$57.1B
$1.39M 1%
18,417
-23,045
-56% -$1.83M
CRZO
53
DELISTED
Carrizo Oil & Gas Inc
CRZO
$1.39M 1%
28,160
+3,790
+16% +$197K
ZLTQ
54
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$1.38M 0.99%
46,765
-17,145
-27% -$518K
IPHI
55
DELISTED
INPHI CORPORATION
IPHI
$1.37M 0.99%
59,780
-13,585
-19% -$302K
FLTX
56
DELISTED
Fleetmatics Group PLC
FLTX
$1.36M 0.98%
29,140
-815
-3% -$36.1K
PRLB icon
57
Protolabs
PRLB
$1.79B
$1.24M 0.89%
+18,360
New +$1.3M
XPO icon
58
XPO
XPO
$23.6B
$1.23M 0.89%
78,799
-153,389
-66% -$2.49M
EXAM
59
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$1.23M 0.89%
31,396
-542
-2% -$22.3K
RDUS
60
DELISTED
Radius Health, Inc.
RDUS
$1.21M 0.88%
17,935
-2,875
-14% -$134K
TSRO
61
DELISTED
TESARO, Inc.
TSRO
$1.21M 0.87%
20,629
-7,400
-26% -$425K
PGND
62
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
$1.17M 0.85%
+40,955
New +$1.11M
PGTI
63
DELISTED
PGT, Inc.
PGTI
$1.17M 0.84%
+80,720
New +$1M
ABMD
64
DELISTED
Abiomed Inc
ABMD
$1.16M 0.84%
+17,665
New +$1.17M
VCRA
65
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.15M 0.83%
+100,380
New +$1.11M
MMI icon
66
Marcus & Millichap
MMI
$1.16B
$1.13M 0.81%
+24,480
New +$1.04M
XENT
67
DELISTED
Intersect ENT, Inc
XENT
$1.11M 0.8%
+38,795
New +$1.02M
TXTR
68
DELISTED
TEXTURA CORPORATION COM
TXTR
$1.1M 0.8%
39,705
-2,245
-5% -$63.9K
RYL
69
DELISTED
RYLAND GROUP INC
RYL
$1.09M 0.79%
23,540
-8,575
-27% -$381K
SNCR
70
DELISTED
Synchronoss Technologies
SNCR
$1.05M 0.76%
+2,552
New +$1.1M
FORM icon
71
FormFactor
FORM
$8.28B
$1M 0.72%
109,070
-103,210
-49% -$936K
RH icon
72
RH
RH
$3.13B
$963K 0.69%
9,868
-3,595
-27% -$331K
MTSI icon
73
MACOM Technology Solutions
MTSI
$19.2B
$937K 0.68%
+24,500
New +$905K
JACK icon
74
Jack in the Box
JACK
$312M
$881K 0.64%
9,994
-3,725
-27% -$335K
PTLA
75
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$853K 0.62%
18,730
+3,325
+22% +$134K

Similar funds

Lisanti Capital Growth's Q2 2015 Portfolio in Review

As of Q2 2015, Lisanti Capital Growth held 117 positions worth $139M, down 21% from $175M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $54M in Q2 2015, closing 32 positions and reducing 43 holdings. Its most notable exit was Qualys, an estimated $3.57M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Lisanti Capital Growth opened a new position in Lithia Motors worth $2.44M.

  • Lisanti Capital Growth's largest Q2 2015 buy was Lithia Motors: 21,595 shares worth $2.44M.
  • Lisanti Capital Growth added most to Neurocrine Biosciences in Q2 2015, an estimated $777K increase.
  • Lisanti Capital Growth's biggest Q2 2015 reduction was XPO, cutting an estimated $2.49M.
  • Lisanti Capital Growth fully exited Qualys in Q2 2015, selling an estimated $3.57M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $139M portfolio in Q2 2015.
  • Lisanti Capital Growth opened 26 new positions and closed 32 in Q2 2015.
  • Lisanti Capital Growth's portfolio value fell 21% quarter-over-quarter to $139M.

Based on Lisanti Capital Growth's 13F filing for Q2 2015, filed 24 Jul 2015.